👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Prof
Prof Michael Loebinger
Respiratory Medicine
English
8,400+
Patients seen
4
Years in practice
8
Publications
1
Languages spoken
About
Professor Michael Loebinger is a Consultant Respiratory Physician at the Royal Brompton Hospital, where he leads the lung division, and Professor of Practice (Respiratory Medicine) at Imperial College, London. Professor Loebinger undertook his preclinical studies at Cambridge University gaining a First Class Honours in Medical Sciences followed by study at Oxford University for his clinical studies. He was then awarded a Medical Research Council Clinical Research Training Fellowship for studies into the use of adult stem cells in lung disease. This resulted in research published in his PhD, which he was awarded by University College London.
His clinical interests cover all respiratory medicine, however he has particular interest and expertise in respiratory infection. His clinical expertise has led to multiple invitations to give lectures on these conditions nationally and internationally and his central involvement in shaping national services and guidelines. Professor Loebinger co-chaired the National bronchiectasis guidelines and co-wrote the European bronchiectasis guidelines and National non-tuberculous mycobacteria guidelines. He chaired the British Thoracic Society Specialist Advisory Group for respiratory infections (2013-2016) and was secretary and then chair of the European Respiratory Society respiratory infection group (2017 - 2023). He has helped set up national and European research networks, with funding to produce clinical bronchiectasis databases and is the recipient of several prestigious research grants. He also collaborates with Industry and is global, national and site principal investigator of multicentre international clinical trials. He has won young investigator of the year awards from the Royal Society of Medicine, the European Respiratory Society, the British Thoracic Society and the British Association of Lung Research. In addition, he has won prestigious awards from the American Thoracic Society, the Medical Research Society and the British Lung Foundation and was awarded the European Respiratory Society research award for innovation in non-tuberculous mycobacteria in 2018. He has been awarded NHS National Clinical Impact and National Clinical Excellence Awards. He has published over 200 articles listed on https://www.imperial.ac.uk/people/m.loebinger/publications.html
His clinical interests cover all respiratory medicine, however he has particular interest and expertise in respiratory infection. His clinical expertise has led to multiple invitations to give lectures on these conditions nationally and internationally and his central involvement in shaping national services and guidelines. Professor Loebinger co-chaired the National bronchiectasis guidelines and co-wrote the European bronchiectasis guidelines and National non-tuberculous mycobacteria guidelines. He chaired the British Thoracic Society Specialist Advisory Group for respiratory infections (2013-2016) and was secretary and then chair of the European Respiratory Society respiratory infection group (2017 - 2023). He has helped set up national and European research networks, with funding to produce clinical bronchiectasis databases and is the recipient of several prestigious research grants. He also collaborates with Industry and is global, national and site principal investigator of multicentre international clinical trials. He has won young investigator of the year awards from the Royal Society of Medicine, the European Respiratory Society, the British Thoracic Society and the British Association of Lung Research. In addition, he has won prestigious awards from the American Thoracic Society, the Medical Research Society and the British Lung Foundation and was awarded the European Respiratory Society research award for innovation in non-tuberculous mycobacteria in 2018. He has been awarded NHS National Clinical Impact and National Clinical Excellence Awards. He has published over 200 articles listed on https://www.imperial.ac.uk/people/m.loebinger/publications.html
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Prof Michael Loebinger
Education & training
-
2012–2018 MD · Medicine and Surgery
-
2018–2022 Residency · Respiratory Medicine
Career & appointments
-
2022-09–2023-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Respiratory Medicine
Malpractice insurance:
AmTrust Europe · 5,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 750 |
| Annual physical exam | 99395 | 1,080 |
| Vaccination administration | 90471 | 408 |
| Minor procedure (skin) | 17110 | 1,711 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 720.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 630.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 13 · i10: 5
-
Validation of clinical scoring in Respiratory Medicine
DOI: 10.1073/euroclin.2026.0 · PMID: 39325869 · cited by 6
-
Long-term follow-up of Respiratory Medicine across
DOI: 10.8288/euroclin.2025.1 · PMID: 33232970 · cited by 36
-
Validation of clinical scoring in Respiratory Medicine
DOI: 10.9538/euroclin.2024.2 · PMID: 37321964 · cited by 146
-
Long-term follow-up of Respiratory Medicine across
DOI: 10.8059/euroclin.2023.3 · PMID: 32849907 · cited by 16
Invited talks
- Practical updates in Respiratory Medicine European Annual Congress (Respiratory Medicine) · Vienna · 2024 · invited
- Single-centre experience in Respiratory Medicine National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Respiratory Medicine — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2023
- national college of family doctors — Member · since 2023
- European Union of Medical Specialists (UEMS) — Member · since 2023
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Respiratory Medicine
- Awareness When should you see a respiratory medicine?
For international patients
- Coordinator
- Patient liaison · professor.michael.loebinger.1@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
